What dose (in international units) of rabies vaccine should be given per intramuscular injection for a typical adult?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 14, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Rabies Vaccine Dose Per Injection

Each dose of rabies vaccine contains 1.0 mL administered intramuscularly, regardless of age, weight, or whether it's for pre-exposure or post-exposure prophylaxis. 1, 2

Dosing Details

The standard dose is consistently 1.0 mL per injection for all FDA-approved rabies vaccines (HDCV and PCECV) used in the United States. This volume-based dosing applies universally:

  • Adults and older children: 1.0 mL IM in the deltoid muscle
  • Infants and small children: 1.0 mL IM in the anterolateral thigh
  • All age groups receive the same volume - there is no weight-based adjustment for the vaccine itself 1, 2

Important Clarification: International Units vs. Volume

The question asks about "units" of vaccine, but rabies vaccine dosing in the U.S. is specified by volume (mL), not international units (IU). International units are used only for rabies immune globulin (RIG), which is dosed at 20 IU/kg body weight 1, 3.

Post-Exposure Prophylaxis Schedules

Previously Unvaccinated Persons:

  • 4-dose regimen (current ACIP recommendation): 1.0 mL IM on days 0,3,7, and 14 1
  • 5-dose regimen for immunosuppressed: 1.0 mL IM on days 0,3,7,14, and 28 1, 2
  • Plus RIG 20 IU/kg on day 0

Previously Vaccinated Persons:

  • 2-dose regimen: 1.0 mL IM on days 0 and 3 1
  • No RIG needed

Pre-Exposure Prophylaxis:

  • 3-dose series: 1.0 mL IM on days 0,7, and 21 or 28 2

Critical Administration Points

Never administer in the gluteal area - this results in significantly lower neutralizing antibody titers and has been associated with vaccine failures 1, 3, 2. The deltoid (adults) or anterolateral thigh (young children) are the only acceptable sites.

The vaccine should never be mixed with RIG in the same syringe or administered at the same anatomic site as the first vaccine dose, though subsequent vaccine doses can be given at the same location where RIG was administered 1, 3.

Related Questions

What is the recommended intradermal dose of rabies vaccine?
In a previously vaccinated individual who received anti‑rabies vaccine one year ago, what is the recommended dosage and schedule of anti‑rabies vaccine (ARV) for a new exposure?
Is the inactivated rabies vaccine safe and indicated for use in pregnant women who have been exposed to a potentially rabid animal or require pre‑exposure prophylaxis?
Is a three-dose rabies vaccination sufficient for adults as pre-exposure prophylaxis?
If I received only one rabies vaccine dose 20 years ago, how should I be managed after a potential exposure?
What is the appropriate cefazolin dosing, treatment duration, renal dose adjustment, and alternative therapy for a patient with a pigtail catheter who has a severe β‑lactam allergy?
The patient stopped metformin 1000 mg twice daily for two weeks and now wants refills; should we restart it at the same dose?
What are the possible differential diagnoses for morning knee soreness that improves with movement and is localized under the patella?
How does Ultomiris (ravulizumab) differ in mechanism of action from Soliris (eculizumab)?
What does a urine pH below 5 indicate and what are the possible underlying causes?
Given a negative full sexually transmitted infection panel (including HIV RNA) performed 20 days after two unprotected sexual encounters, what is the probability that any infection will be detected at a 100–120‑day follow‑up screening, assuming no further exposures and no PrEP use?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.